CEO: Stephen R. Davis

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: ACADIA Pharmaceuticals Inc is a biotechnology company which develops and commercializes biopharmaceutical products to address central nervous system disorders. It aims to discover small molecule drugs to address Parkinson's, Alzheimer's and schizophrenia.


Key numbers

Market Capitalization:7100552500
Shares Outstanding: 154025000
Float: 153173703.825
Next Earning Date:2020-02-25
TTm EPS: -1.7584
TTm Dividend Rate:
200 days moving average:29.65
50 days moving average: 41.03
One day percent Change: 0.2



2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31,
2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,